Novavax
NVAX
11.22
-0.10
-0.88%
Novavax
US · NVAX
#2865 by market cap
Listed 1970
11.22
-0.10
-0.88%
Live - 5344 symbols - heartbeat 394s ago
· 2026-10-08 06:47
Pre-market
11.06
-1.46%
After-hours
11.16
-0.53%
Overnight
11.03
-1.69%
- Market cap
- 1.85B
- P/E (TTM)i
- -8.31
- P/Bi
- -9.71
- EPSi
- 2.58
- Div yieldi
- 0.00%
- 52W posi
- 70%
Reader sentiment
Are you bullish or bearish on NVAX?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 3 analysts
Hold
Avg price target
11.33 +1.0%
Price target rangecurrent 11.22
Low7.00
Avg11.33
High18.00
Buy 33%
Hold 33%
Sell 33%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-18 | BofA Securities | -- | SELL | 7.00 |
| 2026-08-07 | BofA Securities | -- | SELL | 7.00 |
| 2026-08-06 | Cantor Fitzgerald | -- | BUY | 18.00 |
| 2026-08-04 | TD Cowen | -- | HOLD | 9.00 |
| 2026-08-03 | TD Cowen | -- | HOLD | 9.00 |
| 2026-07-07 | BofA Securities | -- | SELL | 8.00 |
| 2026-06-11 | BTIG | -- | BUY | 19.00 |
| 2026-05-07 | Citi | -- | SELL | 7.00 |
| 2026-05-06 | TD Cowen | -- | HOLD | 9.00 |
| 2026-04-21 | H.C. Wainwright | -- | BUY | 16.00 |
| 2026-04-09 | B. Riley Securities | -- | BUY | 18.00 |
| 2026-02-27 | BofA Securities | -- | SELL | 8.00 |
| 2026-02-27 | Citi | -- | SELL | 7.00 |
| 2026-02-27 | H.C. Wainwright | -- | BUY | 16.00 |
| 2026-02-13 | BofA Securities | -- | SELL | 7.00 |
| 2026-02-06 | BofA Securities | -- | SELL | 7.00 |
| 2026-01-30 | BofA Securities | -- | SELL | 7.00 |
| 2026-01-30 | Citi | -- | SELL | 6.00 |
| 2026-01-22 | BofA Securities | -- | SELL | 7.00 |
| 2026-01-20 | BTIG | -- | BUY | 19.00 |
| 2026-01-20 | BofA Securities | -- | SELL | 7.00 |
| 2026-01-20 | H.C. Wainwright | -- | BUY | 11.00 |
| 2026-01-16 | BofA Securities | -- | SELL | 6.00 |
| 2026-01-15 | BofA Securities | -- | SELL | 6.00 |
| 2026-01-13 | Cantor Fitzgerald | -- | BUY | 18.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Hold
Analyst consensus
Hold
All 2 views agree: neutral.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-06 | -- | ±8.47% | +0.52% (in line) |
| 2026/Q1 | 2026-05-06 | -- | ±9.38% | +15.56% (beat) |
| 2025/Q3 | 2025-11-06 | -- | ±12.65% | -1.30% (in line) |
| 2025/Q2 | 2025-08-06 | -- | ±15.41% | +12.63% (in line) |
| 2025/Q1 | 2025-05-08 | -- | ±16.27% | +11.93% (in line) |
| 2024/Q4 | 2025-02-27 | -- | ±18.85% | -3.55% (in line) |
| 2024/Q3 | 2024-11-12 | -- | ±20.78% | -6.10% (in line) |
| 2024/Q2 | 2024-08-08 | -- | ±18.37% | +9.06% (in line) |
| 2024/Q1 | 2024-05-10 | -- | ±16.13% | +98.66% (beat) |
| 2023/Q4 | 2024-02-28 | -- | ±19.93% | -26.74% (beat) |
| 2023/Q3 | 2023-11-09 | -- | ±16.16% | -1.32% (in line) |
| 2023/Q2 | 2023-08-08 | -- | ±19.81% | -3.86% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 06:47:28 · For reference only, not investment advice and not tailored to your situation.